Systems-based discovery advances drug development

S. A. Waldman, A. Terzic

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Drug development expenditures continue to escalate, in part reflecting inefficiencies in current drug discovery paradigms. Traditional drug discovery has been dichotomous, focusing either on phenotypic effects of distinct agents in biological systems, without knowledge of respective targets, or on target-based activities of specific molecules in cell-free assays. Driven by advances in biology, engineering, and informatics, new paradigms integrate phenotypic with target-based algorithms into comprehensive, systems-level approaches offering value-added strategies for optimized drug discovery.

Original languageEnglish (US)
Pages (from-to)285-287
Number of pages3
JournalClinical pharmacology and therapeutics
Issue number4
StatePublished - Apr 2013

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Systems-based discovery advances drug development'. Together they form a unique fingerprint.

Cite this